Thus, YTHDF1, YTHDF2, and YTHDF3 exert irreplaceable functions to foster BC progression and potentially even become robust therapeutic targets for prognostic stratification and effective treatment of BC. This evidence concerns the gene YTHDF1 and breast cancer.